Private Placement

As SAB Biotherapeutics prepares for key investor talks, a closer look reveals its novel T1D therapy and the unique bovine tech aiming to change treatment.

Halia Therapeutics is betting on a novel target to fight chronic inflammation. At a key summit, it will pitch its unique approach for cancer, obesity, and Alzheimer's.

The biopharma company's strategic bid for non-dilutive funding could advance a first-in-class therapy for severe, untreated skin conditions.

A new study reveals a massive shift in perception, with pro gaming now a top career choice for Gen Z, backed by a multi-billion dollar industry.

As Mike Eastwood retires, new CFO Gary Bischoping, a tech and finance veteran, is set to guide the company's ambitious AI transformation and next chapter of growth.

The New York-based bank will now originate FHA-insured loans nationwide, positioning it to capitalize on the growing demand for senior care facilities.

Lynk Pharmaceuticals reports its oral drug zemprocitinib met all goals in a late-stage study for atopic dermatitis, offering rapid itch relief and a strong safety profile.

As MSA Awareness Month begins, a novel drug from Alterity Therapeutics shows significant promise in slowing the devastating and untreatable neurodegenerative disease.

A key clinical milestone for its MS drug azer-cel nets Precision BioSciences $7.5M, extending its financial runway and boosting hope for patients.

With star-studded advisory board, a new biotech firm aims to turn routine dental visits into a frontline defense against oral cancer.

Indian firm Genus Power surpasses 26M smart meter deployments, leveraging its dominant role in national grid reform to expand its footprint worldwide.

Digital pen inventor Anoto reports shrinking sales but better margins, leaning on a high-stakes loan to fuel its strategic reboot in a competitive market.

Facing delisting for being a 'public shell,' XTL Biopharma plans an appeal while its new acquisition and valuable IP hang in the balance.

Novos Power and WearableDose win FedTech's Crucible competition, highlighting critical innovations in power grid stability and real-time radiation monitoring.

French marketing giant DEKUPLE reports stellar 2025 growth, driven by strategic acquisitions, AI integration, and a bold international expansion strategy.

A new Vancouver development is being called a 'gold standard' for community housing, combining 300+ homes with a health centre to revitalize Chinatown.

Electric outboard maker Flux Marine hires Mercury Marine's former strategy head, signaling a push from niche tech to mainstream market dominance.

MONAT Global is the #1 direct seller of premium haircare for a fourth year. We explore the strategy, science, and controversy behind its market dominance.

With U.S. cancer centers tripling adoption of its targeted drug delivery device, RenovoRx signals a potential shift in treating solid tumors.

With new funding and veteran US leadership, UK-based OSSTEC is preparing to launch its innovative ASCENT partial knee system in a competitive market.